TLR2 and COVID-19: In conclusion, low secretion of IL-8 was observed upon stimulation with TLR2, TLR4, TLR7/8, TLR9, and NOD2 agonists by the blood cells of COVID-19 patients at hospital admission and was restored after two weeks of hospitalization, which may be a contributing factor to immunosuppression.